Company Analysis
- Mergers & acquisitions - Looking Forward to 2009
Mar 2009
The pharmaceutical industry has always been characterised by mergers and acquisitions (M&A), with deals often running into tens of billions of dollars. This was thought to have reached a peak... more - Mergers & acquisitions - Death of the Megadeal
Apr 2008
The merger and acquisition (M&A) landscape of the pharma industry has always been a vital indicator of growth for business, and is often punctuated by huge ‘megadeals’ which can affect the entire industry... more - Celldex & Avant - Advancing In Tandem
Feb 2008
On 22nd October 2007, Celldex Therapeutics Inc. and Avant Immunotherapeutics Inc. announced a definitive agreement to merge, to create a NASDAQ-listed, fully-integrated biopharmaceutical company combining the two under the name Avant... more - Hoffmann-La Roche - Innovating in Healthcare
Dec 2007
In the past, it has been standard practice for pharmaceutical companies to develop drugs that have blockbuster potential by being 'one-size-fits-all'. However, this model of drug development is now under reconsideration.. more - AstraZeneca: The battle for late-stage stability
Oct 2007
AstraZeneca is one the most recognized brands in global healthcare today. With over 66,000 employees worldwide and with sales in 2006 of US$26.5 billion, it represents a major force in the pharmaceutical industry.. more - Institute for OneWorld Health : 'Heal the Sick: Stating the Obvious?'
Aug 2007
OneWorld Health is the US’s first not-for-profit pharmaceutical organization, attracting many heavyweight pharmaceutical partners to assist in its non-profit process, with funding mainly provided by the Bill and Melinda Gates Foundation.. more - Garnier's Strategic Kingdom: GSK's road to success
Jun 2007
GlaxoSmithKline (GSK) is one of the top pharmaceutical companies in the world, second only to Pfizer in size, and employs over 100,000 people in 117 countries worldwide. It is a powerhouse of global R&D with perhaps the most significant merger history of all big pharma. more - Genentech : Walking with giants
Mar 2007
Genentech has come a long way in its 30 year history. From being arguably the first true biotech drug company, it has grown to become a Top 30 pharmaceutical concern in terms of its pipeline size.. more - Merck Serono : A new force to be reckoned with?
Feb 2007
September 21st 2006 saw the announcement that Merck KGaA had entered into an agreement with Serono's owners, the Bertarelli family to purchase the majority stake of the Geneva-based company.. more - PowderMed : A golden opportunity for Pfizer
Dec 2006
On the October 9th 2006, global pharmaceutical company Pfizer announced that it was to expand its commitment to fight infectious diseases by entering into an agreement to acquire the private UK-based company PowderMed... more
